Burning Rock Biotech (BNR) Net Cash Flow (2020 - 2025)
Historic Net Cash Flow for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to $1.9 million.
- Burning Rock Biotech's Net Cash Flow rose 11170.62% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.4 million, marking a year-over-year increase of 7236.69%. This contributed to the annual value of -$13.3 million for FY2024, which is 7002.24% up from last year.
- As of Q3 2025, Burning Rock Biotech's Net Cash Flow stood at $1.9 million, which was up 11170.62% from -$9.4 million recorded in Q2 2025.
- Burning Rock Biotech's 5-year Net Cash Flow high stood at $26.1 million for Q1 2021, and its period low was -$79.5 million during Q4 2022.
- Over the past 5 years, Burning Rock Biotech's median Net Cash Flow value was -$13.1 million (recorded in 2023), while the average stood at -$15.8 million.
- Per our database at Business Quant, Burning Rock Biotech's Net Cash Flow plummeted by 22521.44% in 2021 and then soared by 19684.95% in 2024.
- Over the past 5 years, Burning Rock Biotech's Net Cash Flow (Quarter) stood at -$29.2 million in 2021, then crashed by 172.13% to -$79.5 million in 2022, then skyrocketed by 96.76% to -$2.6 million in 2023, then skyrocketed by 196.85% to $2.5 million in 2024, then dropped by 23.01% to $1.9 million in 2025.
- Its Net Cash Flow was $1.9 million in Q3 2025, compared to -$9.4 million in Q2 2025 and -$3.5 million in Q1 2025.